All > Peritoneal Carcinomatosis > Flu

pegsitacianine for Peritoneal Carcinomatosis

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Peritoneal Carcinomatosispegsitacianine - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new cancer-detecting agent that may help improve outcomes for patients with peritoneal carcinomatosis.

Eligible Conditions
  • Peritoneal Carcinomatosis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
IFN-γ (interferon gamma-1b) injection
1
Paclitaxel-loaded tumor penetrating microparticles
1
Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs)

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 30 days

1 day
Clinically Significant Events (CSE)
30 days
Pegsitacianine safety
7 days
Pegsitacianine fluorescence and imaging performance

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Similar Trials

1
IFN-γ (interferon gamma-1b) injection
1
Paclitaxel-loaded tumor penetrating microparticles
1
Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs)

Trial Design

1 Treatment Group

Fluorescence imaging with pegsitacianine
1 of 1

Experimental Treatment

60 Total Participants · 1 Treatment Group

Primary Treatment: pegsitacianine · No Placebo Group · Phase 2

Fluorescence imaging with pegsitacianine
Drug
Experimental Group · 1 Intervention: pegsitacianine · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 30 days

Who is running the clinical trial?

OncoNano Medicine, Inc.Lead Sponsor
2 Previous Clinical Trials
70 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top